Similarly, CSF-1R overexpression induced chemoresistance in ovarian cancer cells via AKT and ERK1/2 pathway activation, while knockdown studies indicated that CSF-1R inhibition increased the apoptotic rate of cisplatin-treated tumor cells [53]. Here, CSF1R is linked to ovarian carcinoma.